Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation‐induced thromboxane B 2 and lipopolysaccharide‐induced prostaglandin E 2 were measured ex vivo and in vitro in human whole blood as indices of COX‐1 and COX‐2 activity. In vitro , acetaminophen elicited a 4.4‐fold selectivity toward COX‐2 inhibition (IC 50 = 113.7 μmol/L for COX‐1;IC 50 = 25.8 μmol/L for COX‐2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX‐1) and 83% (COX‐2). Acetaminophen plasma concentrations remained above the in vitro IC 50 for COX‐2 for at least 5 h postadministration. Ex vivo IC 50 values (COX‐1: 105.2 μmol/L; COX‐2: 26.3 μmol/L) of acetaminophen compared favorably with its in vitro IC 50 values. In contrast to previous concepts, acetaminophen inhibited COX‐2 by more than 80%, i.e. , to a degree comparable to nonste‐roidal antiinflammatory drugs (NSAIDs) and selective COX‐2 inhibitors. However, a >95% COX‐1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX‐2 inhibition, recently defined cardiovascular warnings for use of COX‐2 inhibitors should also be considered for acetaminophen.—Hinz, B., Cheremina, O., Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB J. 22, 383–390 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hinz et al. (2007) demonstrated 4.4x more selectivity toward the inhibition of COX-2 (IC 50 = 25.8 µmol/L) over COX-1 (IC 50 = 113.7 µmol/ L) from in vitro assays using whole human blood [51].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“In this study, paracetamol demonstrated over 80% blockade of COX-2 activity comparable to NSAIDs and COX-2 selective inhibitors.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“It is not clear why there are significant discrepancies in relation to inhibition of COX-1 and COX-2 activities by paracetamol as reported by Hinz et al. [51] and Mitchell et al. [33].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 2×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
The antioxidants of human extracellular fluids
Halliwell, B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,341 · cited 1×
“Thus, the presence of various enzymatic and nonenzymatic antioxidant components in human plasma (33) may explain why acetaminophen elicited the most pronounced COX-2 inhibition in human whole blood as compared to the two other experimental systems.”
ResultSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“Apart from these factors, evidence for COX-2 inhibition by acetaminophen is also supported by previous findings showing that acetaminophen like indomethacin and aspirin confers the synthesis of 18R-hydroxyeicosapentaenoic acid (HEPE) and 15RHEPE through interaction with the COX-2 enzyme (34).”
ResultLangenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123 · cited 1×
“A COXindependent mechanism for the gastrointestinal toxicity of NSAIDs is further supported by findings in COX-1 knockout mice, which still develop gastric erosions in response to oral administration of indomethacin (45).”
BackgroundPharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807 · cited 2×
“A peripheral antiinflammatory action is further supported by findings showing acetaminophen as an inhibitor of nociception and edema in the rat carrageenan footpad model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 2×
“Whereas the drug was first associated with a predominant suppression of PG synthesis in brain tissue ( 3 ), subsequent studies contradicted a cell-specific modulation (4 –7).”
BackgroundMethodMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 4×
“Moreover, it turned out that acetaminophen elicits no measurable inhibition of PG formation in broken cell preparations but a profound suppression in intact cells (7).”
BackgroundInfluentialNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 522 · cited 1×
“PGE2 is the currently most plausible explanation for the cardiovascular hazard conferred by selective and nonselective COX-2 inhibitors (20, 30).”
Background
Research works printed but not linked: 1
- Mantzke U. S., 2002, Paracetamol in childhood. Current state of knowledge and indications for a rational approach to postoperative analgesia, Anaesthesist, 51, 735
Cited by
Items 101–200 of 489
McCarthy, M. K., & Weinberg, J. B. (2012) · Mediators of Inflammation · doi:10.1155/2012/236345 · Cited by 46
“Another group treated influenza-infected mice with paracetamol (acetominophen), a selective inhibitor of COX2 [103, 104].”
BackgroundTakehara, M., Hoshino, T., Namba, T., Yamakawa, N., & Mizushima, T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.012 · Cited by 45
“Itwas recently suggested that this weak inhibition of COX by AAP is responsible for its antiinflammatoryeffect [36].”
BackgroundKanashiro, A., Pessini, A. C., Machado, R. R., Malvar, D. D. C., Aguiar, F. A., Soares, D. M., do Vale, M. L., & de Souza, G. E. P. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90527.2008 · Cited by 41
“In addition, recent studies have demonstrated that paracetamol and dipyrone, which show weak anti-inflammatory but potent antipyretic and analgesic effects, inhibit preferentially COX-2 and both COX-1/-2, respectively (29, 30, 35, 37).”
Masoumi, K., Forouzan, A., Darian, A. A., Feli, M., Barzegari, H., & Khavanin, A. (2014) · Emergency Medicine International · doi:10.1155/2014/571326 · Cited by 41
Meaidi, A., Mascolo, A., Sessa, M., Toft‐Petersen, A. P., Skals, R. G., Gerds, T. A., Skovlund, C. W., Mørch, L. S., Rossi, F., Capuano, A., et al. (2023) · BMJ · doi:10.1136/bmj-2022-074450 · Cited by 41
Stepanović-Petrović, R. M., Micov, A. M., Tomic´, M. A., ́, J. M. K., & Bošković, B. (2013) · Anesthesiology · doi:10.1097/aln.0000435833.33515.ba · Cited by 41
Suciu, M., Lukinich-Gruia, A. T., Nica, D. V., Azghadi, S. M. R., Mic, A. A., & Mic, F. A. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.10.019 · Cited by 40
“Although it is commonly considered that acetaminophen acts directly in the central nervous system, recent data provided evidence for a direct link between this drug and eicosanoids in the human vasculature [45].”
BackgroundWaller, C., THUMSER, A. E. A., Langat, M. K., Crouch, N. R., & Mulholland, D. A. (2013) · Phytochemistry · doi:10.1016/j.phytochem.2013.06.024 · Cited by 40
“but subsequently reinstated by Jessop (1970). In previous pharmacological investigations, homoisoflavanones, commonly occurring constituents in the Hyacinthoideae (Speta, 1998; Pohl et al.”
BackgroundReactive metabolites of acetaminophen activate and sensitize the capsaicin receptor TRPV1
Eberhardt, M. J., Schillers, F., Eberhardt, E. M., Risser, L., de la Roche, J., Herzog, C., Echtermeyer, F., & Leffler, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-13054-3 · Cited by 37
“7B and C white bar, n = 340, ANOVA F(1, 730) = 77.”
Min, J. S., Osborne, V., Kowalski, A., & Prosperi, M. (2017) · Drug Safety · doi:10.1007/s40264-017-0611-5 · Cited by 41
“It is one of the most common over-the-counter (OTC) analgesic drugs used for mild to moderate pain [8].”
NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study
Reese, J., Coleman, B., Chan, L., Blau, H., Callahan, T. J., Cappelletti, L., Fontana, T., Bradwell, K. R., Harris, N. L., Casiraghi, E., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01813-2 · Cited by 41
“A prospective, multicenter cohort study on 78,674 hospitalized COVID-19 patients across 255 health-care facilities in England, Scotland, and Wales showed that NSAID use was not associated with worse in-hospital mortality, critical care admission, requirement for invasive ventilation, requirement…”
Tropisetron blocks analgesic action of acetaminophen: A human pain model study
Bandschapp, O., Filitz, J., Urwyler, A., Koppert, W., & Ruppen, W. (2011) · Pain · doi:10.1016/j.pain.2011.02.003 · Cited by 39
“Moreover, research is still ongoing as to which cyclooxygenase isoform is involved and where the main inhibitory action of acetaminophen takes place, ie, centrally, peripherally, or both [9,15,17,19,28,30].”
Backgroundvan der Horst, J., Manville, R. W., Hayes, K., Thomsen, M. B., Abbott, G. W., & Jepps, T. A. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.313997 · Cited by 41
“APAP’s analgesic mechanism of action is regarded to be through cyclooxygenase (COX) inhibition 10 ; however this hypothesis has come under scrutiny since APAP lacks the adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) that are associated with COX inhibition.”
Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
Esh, C. J., Chrismas, B. C. R., Mauger, A. R., & Taylor, L. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.835 · Cited by 38
In search of an ideal analgesic for common acute pain
Moore, N. D. (2009) · Acute Pain · doi:10.1016/j.acpain.2009.09.003 · Cited by 46
Wu, S., Han, J., & Qureshi, A. A. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-1855 · Cited by 40
“The mechanism of action of acetaminophen is not completely understood, whereas the main mechanism proposed is also the inhibition of COX (8, 9).”
BackgroundAnalgesic effect of dimethyl trisulfide in mice is mediated by TRPA1 and sst 4 receptors
Pozsgai, G., Payrits, M., Sághy, É., Sebestyén-Bátai, R., Steen, E., Szőke, É., Zoltán, S., Solymár, M., Garami, A., Orvos, P., et al. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.01.012 · Cited by 37
Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary
Richman, S., Morris, M. C., Broderick, G., Craddock, T. J. A., Klimas, N. G., & FLETCHER, M. A. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.02.011 · Cited by 39
Golding, J., Gregory, S., Clark, R., Ellis, G. L., Iles‐Caven, Y., & Northstone, K. (2019) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12582 · Cited by 40
Oluwabunmi, I., & Abiola, T. S. (2015) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.149238 · Cited by 37
“I is of pivotal importance in anti‑inflammatory response of NSAIDs.”
What Are Endocrine Disrupters and Where Are They Found?
Darbre, P. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801139-3.00001-6 · Cited by 36
Modeling the effects of commonly used drugs on human metabolism
Sahoo, S., Haraldsdóttir, H. S., Fleming, R. M. T., & Thiele, I. (2014) · FEBS Journal · doi:10.1111/febs.13128 · Cited by 38
Ray, S., Salzer, I., Kronschläger, M. T., & Boehm, S. (2019) · Pain · doi:10.1097/j.pain.0000000000001474 · Cited by 35
Acetaminophen Use and Risk of Myocardial Infarction and Stroke in a Hypertensive Cohort
Fulton, R. L., Walters, M. R., Morton, R., Touyz, R. M., Dominiczak, A. F., Morrison, D. S., Padmanabhan, S., Meredith, P. A., McInnes, G. T., & Dawson, J. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04945 · Cited by 35
The antinociceptive effect of acetaminophen in a rat model of neuropathic pain
Im, K., Jung, H., Kim, J., Lee, J., Park, H. J., Joo, C. H., & Moon, D. E. (2012) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2011.11.003 · Cited by 35
Abuaf, N., Rostane, H., Barbara, J., Toly‐Ndour, C., Gaouar, H., Mathelier‐Fusade, P., Leynadier, F., Francès, C., & Girot, R. (2011) · Journal of Allergy · doi:10.1155/2012/580873 · Cited by 35
“It remains a weak COX inhibitor, but it is more potent in inhibiting COX-2 than COX-1, like selective COX-2 inhibitors [17].”
BackgroundMuroi, C., Hugelshofer, M., Seule, M. A., & Keller, E. (2013) · Neurocritical Care · doi:10.1007/s12028-013-9930-2 · Cited by 35
“However, it is noteworthy that this statement is based largely on early works showing that acetaminophen does not suppress inflammation associated with rheumatoid arthritis, whereas anti-inflammatory action has been supported in different types of inflammatory conditions and the mechanism of action has been suggested…”
BackgroundInfluentialTiming of ibuprofen use and bone mineral density adaptations to exercise training
Kohrt, W. M., Barry, D. W., Pelt, R. E. V., Jankowski, C. M., Wolfe, P., & Schwartz, R. S. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.24 · Cited by 39
“However, recent evidence suggests that acetaminophen does, indeed, act through COX-related mechanisms.((11,15)) To our knowledge, the effect of acetaminophen on the bone-formation response to loading has not been studied.”
BackgroundMethodBilavendran, J. D., Alagumuthu, M., Thangarasu, P., & Sivakumar, K. K. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103484 · Cited by 34
Jeyamogan, S., Khan, N. A., Anwar, A., Shah, M. R., & Siddiqui, R. (2018) · SAGE Open Medicine · doi:10.1177/2050312118781962 · Cited by 33
Synergism between COX-3 inhibitors in two animal models of pain
Muñoz, J., Navarro, C., Noriega, V., Pinardi, G., Sierralta, F., Prieto, J. C., & Miranda, H. F. (2010) · Inflammopharmacology · doi:10.1007/s10787-009-0019-7 · Cited by 33
Paracetamol, NSAIDS and opioid analgesics for chronic low back pain: a network meta-analysis
Bagg, M. K., McLachlan, A. J., Maher, C. G., Kamper, S. J., Williams, C. M., Henschke, N., Wand, B. M., Moseley, G. L., Hübscher, M., O'Connell, N. E., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013045 · Cited by 34
“Paracetamol also inhibits the COX-1 and COX-2 enzymes (Graham 2013; Jozwiak-Bebenista 2014), particularly COX-2 (Graham 2013; Hinz 2008; Hinz 2012).”
BackgroundCorrea, A. S., de Almeida, V. L., Lopes, B. M. V., Franco, A., de Matos, F. R., Quintans‐Júnior, L. J., Rode, S. D. M., & Paranhos, L. R. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720160865 · Cited by 32
Mohammadi, M., & Khanmohammadi, A. (2020) · Theoretical Chemistry Accounts · doi:10.1007/s00214-020-02650-8 · Cited by 31
Temperature Regulation and the Pathogenesis of Fever
Sajadi, M. M., & Mackowiak, P. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00055-2 · Cited by 31
Using pharmacokinetic principles to optimize pain therapy
Brune, K., Renner, B., & Hinz, B. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.141 · Cited by 34
“However, both drugs block COX2 sufficiently (>80%) at therapeutic doses to achieve analgesic effects”
BackgroundSelf-citationAl-Belooshi, T., John, A., Tariq, S., Al-Otaiba, A., & Raza, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.06.031 · Cited by 29
The use of different analgesics in orthodontic tooth movements
Hammad, S. M., Elhawary, Y. M., & El-Hawary, A. K. (2012) · The Angle Orthodontist · doi:10.2319/110911-691.1 · Cited by 28
“The main mechanism proposed is considered to be the inhibition of COX, and recent findings suggest that it is highly selective for COX-2.(10) It was thought that it blocked a third isoform, COX-3, which is expressed only in the brain and the spinal cord.”
BackgroundInfluentialAcetaminophen (Paracetamol): Use beyond Pain Management and Dose Variability
Esh, C., Mauger, A. R., Palfreeman, R., Al-Janubi, H., & Taylor, L. K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01092 · Cited by 32
“The human specific general consensus within the literature, is that the inhibition of COX isoforms, COX1 (maintains homeostasis) and COX2 [combats pathophysiological states including inflammation, pain and fever (Fitzpatrick, 2004; Hinz et al., 2008; Rouzer and Marnett, 2009; Hinz and Brune, 2012; Graham et al., 2013;…”
BackgroundPergolizzi, J. V., Raffa, R. B., Tallarida, R. J., Taylor, R., & Labhsetwar, S. A. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00476.x · Cited by 29
Acetaminophen use and change in blood pressure in a hypertensive population
Dawson, J., Fulton, R., McInnes, G. T., Morton, R., Morrison, D., Padmanabhan, S., Hewitt, J., Meredith, P., Muir, S., Dominiczak, A. F., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328360f6f8 · Cited by 27
“Recent data suggest that acetaminophen acts through an indirect effect on the COX-2 enzyme [5,13] and perhaps on a central splice variant of this enzyme, COX-3 [6].”
BackgroundTiippana, E., Hamunen, K., Kontinen, V., & Kalso, E. A. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00935.x · Cited by 29
Drug-induced hypertension: Know the problem to know how to deal with it
Masi, S., Uliana, M., Gesi, M., Taddei, S., & Virdis, A. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.02.002 · Cited by 32
Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63
Díaz‐Rodríguez, L., García‐Martínez, O., Arroyo‐Morales, M., Rubio‐Ruíz, B., & Ruíz, C. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.129 · Cited by 31
Messerer, B., Grögl, G., Stromer, W., & Jaksch, W. (2014) · Der Schmerz · doi:10.1007/s00482-013-1384-0 · Cited by 27
Girard, P., Sourdet, S., Cantet, C., Barreto, P. D. S., & Rolland, Y. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15861 · Cited by 27
“It is reported that it acts in a way similar to nonsteroidal anti-inflammatory drugs (NSAIDs) with a twist.(4,24) Cyclooxygenase inhibition (COX 1 and COX 2) results in diminished prostaglandin (PG) synthesis at low rates,(4) bringing about the validation of synergistic use with NSAID in pain management(25) but is not…”
BackgroundCan drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology
Hinz, B., & Brune, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.004 · Cited by 28
Self-citationNew problems arising from old drugs: second-generation effects of acetaminophen
Tiegs, G., Karimi, K., Brune, K., & Arck, P. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.944502 · Cited by 27
“APAP has been shown to preferentially inhibit COX-2 [44].”
BackgroundSelf-citationGump, B. S., McMullan, D. R., Cauthon, D. J., Whitt, J. A., Mundo, J. D. D., Letham, T., Kim, P. J., Friedlander, G. N., Pingel, J., Langberg, H., et al. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00219.2013 · Cited by 27
Idborg, H., Pawelzik, S., Pérez‐Manso, M., Björk, L., Hamrin, J., Herlenius, E., & Jakobsson, P. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.09.006 · Cited by 26
“Acetaminophen is a selective COX-2 inhibitor at pharmacological relevant levels and reduce the inflammation-induced production of prostaglandins and thus fever [37,39,40].”
BackgroundSuemaru, K., Yoshikawa, M., Tanaka, A., Araki, H., Aso, H., & Watanabe, M. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.12.004 · Cited by 26
D’Lugos, A. C., Patel, S. H., Ormsby, J. C., Curtis, D., Fry, C. S., Carroll, C. C., & Dickinson, J. M. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00922.2017 · Cited by 29
“However, the dosing strategy employed in the present study has been previously shown to elicit a bioavailability steady state of APAP (43) and a plasma APAP concentration that remains above the IC50 for COX-2 inhibition for ~6 h after ingestion (20).”
BackgroundMethodInfluentialOld Drug, New Route: A Systematic Review of Intravenous Acetaminophen After Adult Cardiac Surgery
Douzjian, D. J., & Kulik, A. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.03.134 · Cited by 26
Effect of Acetaminophen Ingestion on Thermoregulation of Normothermic, Non-febrile Humans
Foster, J., Mauger, A., Thomasson, K., White, S., & Taylor, L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00054 · Cited by 25
Mason, A. E., Kasl, P., Hartogensis, W., Natale, J. L., Dilchert, S., Dasgupta, S., Purawat, S., Chowdhary, A., Anglo, C., Veasna, D., et al. (2022) · Vaccines · doi:10.3390/vaccines10020264 · Cited by 27
“As antipyretic analgesics, including acetaminophen [27] and non-steroidal anti-inflammatory drugs, can inhibit COX-2, these data have raised concerns that antipyretic analgesics might blunt certain vaccine responses if given at the time of vaccination.”
BackgroundArden, N., Hauber, B., Mohamed, A. F., Johnson, F. R., Peloso, P. M. J., Watson, D. J., Mavros, P., Gammaitoni, A. R., Sen, S. S., & TAYLOR, S. D. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111066 · Cited by 26
Aspirin and Acetaminophen Use and the Risk of Cervical Cancer
Friel, G., Liu, C. S., Kolomeyevskaya, N. V., Hampras, S. S., Kruszka, B., Schmitt, K. L., Cannioto, R. A., Lele, S., Odunsi, K. O., & Moysich, K. B. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000104 · Cited by 25
“Not considered an NSAID because of weak anti-inflammatory effects, acetaminophen reversibly inhibits COX-1 and COX-2, with recent evidence confirming selectivity for COX-2.(14) In vitro studies demonstrate overexpression of COX-1 and COX-2 in cervical carcinogenesis.”
BackgroundSingle dose oral analgesics for acute postoperative pain in adults
Moore, R. A., Derry, S., & McQuay, H. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659 · Cited by 25
Effect of antibiotics and NSAIDs on cyclooxygenase-2 in the enamel mineralization
Muñoz, C. S., Silva, A. P., Solano, F., Castells, M. T., Vicente, A., & Ruiz, A. J. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-22607-z · Cited by 24
Comprehensive biology of antipyretic pathways
Prajitha, N., Athira, S. S., & Mohanan, P. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.008 · Cited by 24
Non‐steroidal anti‐inflammatory drugs and risk of pulmonary embolism
Biere‐Rafi, S., Nisio, M. D., Gerdes, V. E. A., Porreca, E., Souverein, P. C., de Boer, A., Buller, H. R., & Kamphuisen, P. W. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2130 · Cited by 24
“Furthermore, although we assumed no effect of acetaminophen on hemostasis, there are some studies that suggest that it may be a selective COX inhibitor.(18) To our knowledge, no such association has been reported for tramadol, which showed the strongest association.”
BackgroundSolar, P., Mackerle, Z., Joukal, M., & Jančálek, R. (2020) · Neurosurgical Review · doi:10.1007/s10143-020-01276-5 · Cited by 23
“However, acetaminophen (paracetamol) is a selective COX-2 inhibitor with some effect on the inflammatory response including suppression of prostaglandin synthesis in the central nervous system [11].”
BackgroundChoosing and using non‐steroidal anti‐inflammatory drugs in haemophilia
Arachchillage, D. J., & Makris, M. (2015) · Haemophilia · doi:10.1111/hae.12805 · Cited by 23
Aspirin and acetaminophen: Should they be available over the counter?
Brune, K., Hinz, B., & Otterness, I. G. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0006-4 · Cited by 32
Self-citationWu, J.-P., & Li, M. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.02.022 · Cited by 23
Sultana, N., Arayne, M. S., Siddiqui, R., & Naveed, S. (2012) · American Journal of Analytical Chemistry · doi:10.4236/ajac.2012.32021 · Cited by 23
“Non-steroidal anti-inflammatory drugs (NSAIDs) usually indicated for the treatment of acute or chronic pain and inflammation are nonselective inhibitors of cyclooxygenase, inhibiting both cyclooxygenase-1 and cyclooxygenase-2 isoenzymes, which catalyzes the formation of prostaglandins and thromboxane from arachidonic…”
BackgroundBecker, J. H., & Wu, S. (2010) · Journal of the American Podiatric Medical Association · doi:10.7547/1000281 · Cited by 23
Langhendries, J.-P., Allegaert, K., Anker, J. N. V. D., Veyckemans, F., & Smets, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.012 · Cited by 26
Chávez-Monteagudo, J. R., Ibancovichi-Camarillo, J. A., Sánchez-Aparicio, P., Acevedo-Arcique, C. M., Moran-Muñoz, R., & Recillas‐Morales, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143710 · Cited by 24
“[8] showed that acetaminophen is a selective COX-2 inhibitor in humans.”
BackgroundCarroll, C. C., Whitt, J. A., Peterson, A., Gump, B. S., Tedeschi, J. N., & Broderick, T. L. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00659.2011 · Cited by 24
Lipiec, A., Wawrzyniak, Z. M., Sybilski, A. J., Samolińska-Zawisza, U., Krzych‐Fałta, E., Piekarska, B., Dulny, G., Stankiewicz-Choroszucha, B., Raciborski, F., & Samolinski, B. K. (2018) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/86336 · Cited by 22
“The suspected mechanisms behind the observed correlations involve oxidative stress in the airways with its effect on inflammation, as well as a strong Th2-mediated response [15, 16] or airway epithelial damage as the effect of inhibiting cyclooxygenase-2, which plays a role in the repair of damaged airway epithelium […”
BackgroundCombined Quantum Mechanics and Molecular Mechanics Studies of Enzymatic Reaction Mechanisms
Ainsley, J., Lodola, A., Mulholland, A. J., Christov, C. Z., & Karabencheva‐Christova, T. G. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.07.001 · Cited by 22
COX-3: Uncertainties and controversies
Kam, P. C. A., & So, A. (2008) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2008.11.003 · Cited by 26
Huang, K., Masuda, A., Chen, G., Bushra, S., Kamon, M., Araki, T., Kinoshita, M., Ohkawara, B., Ito, M., & Ohno, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59517-y · Cited by 21
Carroll, C. C., Martineau, K., Arthur, K. A., Huynh, R. T., Volper, B. D., & Broderick, T. L. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00374.2014 · Cited by 22
“Substantial evidence also highlights the fact that APAP is a selective inhibitor of cyclooxygenase-2 (16), which has led to some concern that APAP may hold similar risk of cardiovascular events that have been reported for other selective COX-2 inhibitors (15).”
BackgroundTomic´, M. A., Vučković, S., Stepanović-Petrović, R. M., Ugrešić, N. D., Prostran, M. S., & Bošković, B. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181cbd8da · Cited by 21
Fracon, R. N., Teófilo, J. M., Moris, I. C. M., & Lamano, T. (2010) · Journal of Applied Oral Science · doi:10.1590/s1678-77572010000600016 · Cited by 21
Does 1 or 2 g paracetamol added to ketoprofen enhance analgesia in adult tonsillectomy patients?
SALONEN, A., Silvola, J. T., & Kokki, M. (2009) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2009.02035.x · Cited by 21
Gualtierotti, R., Zoppi, A., Mugellini, A., Derosa, G., D’Angelo, A., & Fogari, R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.816286 · Cited by 25
“Thus the pressor effect of acetaminophen could be mediated by such central COX-3 activity beside COX-2 inhibition [38].”
BackgroundSuda, N., Hernandez, J. C., Poulton, J., Jones, J. P., Konsoula, Z., Smith, C., & Parker, W. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253543 · Cited by 20
“Acetaminophen inhibits cyclo-oxygenase enzymes [34], which are necessary for the production of Prostaglandin E2, a lipid normally present in the brain of laboratory animals and humans.”
BackgroundRoom for improvement: unmet needs in postoperative pain management
Pogatzki-Zahn, E. M., Schnabel, A., & Zahn, P. K. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.30 · Cited by 23
Zhang, J., Zhu, H., Chen, Y., Li, C., Li, C., Chu, H., Gozali, L., Lee, A. C.-Y., To, K. K., Hung, I. F., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy527 · Cited by 21
A Large Cohort Study of Long-term Acetaminophen Use and Prostate Cancer Incidence
Jacobs, E. J., Newton, C. C., Stevens, V. L., & Gapstur, S. M. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0210 · Cited by 22
“One recent study reported that a standard clinical dose of acetaminophen reduced COX-2 activity in whole blood as much as a standard clinical dose of the selective COX-2 inhibitor celecoxib (21).”
BackgroundRoca-Vinardell, A., Berrocoso, E., Llorca-Torralba, M., Garcia-Partida, J. A., Gibert‐Rahola, J., & Micó, J. A. (2018) · Neurobiology of Pain · doi:10.1016/j.ynpai.2018.01.004 · Cited by 20
“Paracetamol has been shown to act as a selective COX-2 inhibitor in the CNS, where the concentration of tissue peroxides is low unlike at sites of inflammation (Hinz et al., 2008; Lee et al., 2007).”
BackgroundAyoub, S. S., & Flower, R. J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172609 · Cited by 19
Zhang, J., Yang, Z., Liu, C., Wan, H., Hao, Z., Ji, X., Wang, P., Yi, H., & Lei, A. (2024) · Nature Communications · doi:10.1038/s41467-024-51327-4 · Cited by 19
“Paracetamol, a widely utilized analgesic and antipyretic agent, stands out for its favorable side effect pro fi le 3,4 .”
BackgroundMolecular Docking and dynamic simulation analysis of flavonoid derivatives as COX-2 inhibitors
Janakiramulu, P., & Mamidala, E. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00349-x · Cited by 19
“Given the lim - itations of current COX-2 inhibitors like Celecoxib, Rofe-coxib, and Etoricoxib, which are associated with severe side effects such as myocardial infarction, arterial thrombosis, and increased vascular events, there is an urgent need to explore safer alternatives (Hinz et al. 2008).”
Micov, A. M., Tomic´, M. A., Pecikoza, U. B., Ugrešić, N. D., & Stepanović-Petrović, R. M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.014 · Cited by 20
Impairment of aspirin antiplatelet effects by non-opioid analgesic medication
Polzin, A., Hohlfeld, T., Kelm, M., & Zeus, T. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i7.383 · Cited by 24
Acquired Disorders of Platelet Function
Rao, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00051-1 · Cited by 19
Santacroce, L., Colella, M., Charitos, I. A., Domenico, M. D., Palmirotta, R., & Jirillo, E. (2023) · Metabolites · doi:10.3390/metabo13030461 · Cited by 19
Burtscher, M., Gatterer, H., Philippe, M., Krüsmann, P., Kernbeiss, S., Frontull, V., & Kofler, P. (2013) · Europe PMC (PubMed Central) · Cited by 18
Oğuztürk, H., Ozgur, D., Turtay, M. G., Kayaalp, C., Yılmaz, S., Dogan, M., & Pamukcu, E. (2012) · PubMed · Cited by 18
Foster, J., Mauger, A. R., Chrismas, B. C. R., Thomasson, K., & Taylor, L. K. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.07.022 · Cited by 21
Sinning, C., Watzer, B., Coste, O., Nüsing, R. M., Ott, I., Ligresti, A., Marzo, V. D., & Imming, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800807k · Cited by 18
Klopčič, I., Poberžnik, M., Mavri, J., & Dolenc, M. S. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.002 · Cited by 18
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
Wiffen, P. J., Knaggs, R., Derry, S., Cole, P., Phillips, T., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012227 · Cited by 18
Bashir, S., Elegunde, B., & Morgan, W. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113774 · Cited by 17
Ahmed, O. G., & El-Mottaleb, N. A. A. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0182-y · Cited by 17
“The observed hypertensive effect of acetaminophen may also be mediated by such central COX-3 activity or COX-2 inhibition by acetaminophen [21] or by an indirect activation of a specific cannabinoid CB(1) receptor [9].”
Non-steroidal anti-inflammatory drugs
Patrono, C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00050-6 · Cited by 17
Metadata
- Authors
- Hinz, B., Cheremina, O., & Brune, K.
- Affiliations
- University of Rostock (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- ORCID
- Hinz, Burkhard
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-09-20
- Volume
- 22
- Issue
- 2
- Pages
- 383-390
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2132889863
- Cited by
- 478
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 19 · 2020: 14 · 2019: 28 · 2018: 33 · 2017: 29 · 2016: 35 · 2015: 49 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- paracetamol, COX-2 inhibition, COX-1 inhibition, COX-2 inhibitors, thromboxane B2, prostaglandin E2, plasma pharmacokinetics, gastrointestinal safety, cardiovascular risk, analgesic mechanism, anti-inflammatory mechanism
- MeSH terms
- Acetaminophen, Cells, Cultured, Humans, Isoenzymes, Monocytes, Time Factors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.